COVID-19 Impact on Global Osteoarthritis Therapeutics Market Size, Status and Forecast 2020-2026

July 2020 | 131 pages | ID: C11CC1D3564FEN
QYResearch

Abstracts

This report focuses on the global Osteoarthritis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Osteoarthritis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Johnson & Johnson
• GlaxoSmithKline
• Bayer
• Eli Lilly
• Novartis
• Sanofi
• Horizon Pharma
• Abbott
• Mylan
• Daiichi Sankyo
• TEVA
• Almatica Pharma
• Astellas Pharma
• Tide Pharmaceutical
• Iroko Pharmaceuticals
• Hengrui Pharmaceutical
• Abiogen Pharma

Market segment by Type, the product can be split into

• Oral
• Injection
• External

Market segment by Application, split into

• Medical Care
• Personal Care

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Osteoarthritis Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Osteoarthritis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Osteoarthritis Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Osteoarthritis Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Osteoarthritis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral
  1.4.3 Injection
  1.4.4 External
1.5 Market by Application
  1.5.1 Global Osteoarthritis Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Medical Care
  1.5.3 Personal Care
1.6 Coronavirus Disease 2019 (Covid-19): Osteoarthritis Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Osteoarthritis Therapeutics Industry
    1.6.1.1 Osteoarthritis Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Osteoarthritis Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Osteoarthritis Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Osteoarthritis Therapeutics Market Perspective (2015-2026)
2.2 Osteoarthritis Therapeutics Growth Trends by Regions
  2.2.1 Osteoarthritis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Osteoarthritis Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Osteoarthritis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Osteoarthritis Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Osteoarthritis Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Osteoarthritis Therapeutics Players by Market Size
  3.1.1 Global Top Osteoarthritis Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Osteoarthritis Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Osteoarthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Osteoarthritis Therapeutics Market Concentration Ratio
  3.2.1 Global Osteoarthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Osteoarthritis Therapeutics Revenue in 2019
3.3 Osteoarthritis Therapeutics Key Players Head office and Area Served
3.4 Key Players Osteoarthritis Therapeutics Product Solution and Service
3.5 Date of Enter into Osteoarthritis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Osteoarthritis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Osteoarthritis Therapeutics Forecasted Market Size by Type (2021-2026)

5 OSTEOARTHRITIS THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Osteoarthritis Therapeutics Market Size by Application (2015-2020)
5.2 Global Osteoarthritis Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Osteoarthritis Therapeutics Market Size (2015-2020)
6.2 Osteoarthritis Therapeutics Key Players in North America (2019-2020)
6.3 North America Osteoarthritis Therapeutics Market Size by Type (2015-2020)
6.4 North America Osteoarthritis Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Osteoarthritis Therapeutics Market Size (2015-2020)
7.2 Osteoarthritis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Osteoarthritis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Osteoarthritis Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Osteoarthritis Therapeutics Market Size (2015-2020)
8.2 Osteoarthritis Therapeutics Key Players in China (2019-2020)
8.3 China Osteoarthritis Therapeutics Market Size by Type (2015-2020)
8.4 China Osteoarthritis Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Osteoarthritis Therapeutics Market Size (2015-2020)
9.2 Osteoarthritis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Osteoarthritis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Osteoarthritis Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Osteoarthritis Therapeutics Market Size (2015-2020)
10.2 Osteoarthritis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Osteoarthritis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Osteoarthritis Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Osteoarthritis Therapeutics Market Size (2015-2020)
11.2 Osteoarthritis Therapeutics Key Players in India (2019-2020)
11.3 India Osteoarthritis Therapeutics Market Size by Type (2015-2020)
11.4 India Osteoarthritis Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Osteoarthritis Therapeutics Market Size (2015-2020)
12.2 Osteoarthritis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Osteoarthritis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Osteoarthritis Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Osteoarthritis Therapeutics Introduction
  13.1.4 Pfizer Revenue in Osteoarthritis Therapeutics Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Johnson & Johnson
  13.2.1 Johnson & Johnson Company Details
  13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.2.3 Johnson & Johnson Osteoarthritis Therapeutics Introduction
  13.2.4 Johnson & Johnson Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  13.2.5 Johnson & Johnson Recent Development
13.3 GlaxoSmithKline
  13.3.1 GlaxoSmithKline Company Details
  13.3.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.3.3 GlaxoSmithKline Osteoarthritis Therapeutics Introduction
  13.3.4 GlaxoSmithKline Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  13.3.5 GlaxoSmithKline Recent Development
13.4 Bayer
  13.4.1 Bayer Company Details
  13.4.2 Bayer Business Overview and Its Total Revenue
  13.4.3 Bayer Osteoarthritis Therapeutics Introduction
  13.4.4 Bayer Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  13.4.5 Bayer Recent Development
13.5 Eli Lilly
  13.5.1 Eli Lilly Company Details
  13.5.2 Eli Lilly Business Overview and Its Total Revenue
  13.5.3 Eli Lilly Osteoarthritis Therapeutics Introduction
  13.5.4 Eli Lilly Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  13.5.5 Eli Lilly Recent Development
13.6 Novartis
  13.6.1 Novartis Company Details
  13.6.2 Novartis Business Overview and Its Total Revenue
  13.6.3 Novartis Osteoarthritis Therapeutics Introduction
  13.6.4 Novartis Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  13.6.5 Novartis Recent Development
13.7 Sanofi
  13.7.1 Sanofi Company Details
  13.7.2 Sanofi Business Overview and Its Total Revenue
  13.7.3 Sanofi Osteoarthritis Therapeutics Introduction
  13.7.4 Sanofi Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  13.7.5 Sanofi Recent Development
13.8 Horizon Pharma
  13.8.1 Horizon Pharma Company Details
  13.8.2 Horizon Pharma Business Overview and Its Total Revenue
  13.8.3 Horizon Pharma Osteoarthritis Therapeutics Introduction
  13.8.4 Horizon Pharma Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  13.8.5 Horizon Pharma Recent Development
13.9 Abbott
  13.9.1 Abbott Company Details
  13.9.2 Abbott Business Overview and Its Total Revenue
  13.9.3 Abbott Osteoarthritis Therapeutics Introduction
  13.9.4 Abbott Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  13.9.5 Abbott Recent Development
13.10 Mylan
  13.10.1 Mylan Company Details
  13.10.2 Mylan Business Overview and Its Total Revenue
  13.10.3 Mylan Osteoarthritis Therapeutics Introduction
  13.10.4 Mylan Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  13.10.5 Mylan Recent Development
13.11 Daiichi Sankyo
  10.11.1 Daiichi Sankyo Company Details
  10.11.2 Daiichi Sankyo Business Overview and Its Total Revenue
  10.11.3 Daiichi Sankyo Osteoarthritis Therapeutics Introduction
  10.11.4 Daiichi Sankyo Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  10.11.5 Daiichi Sankyo Recent Development
13.12 TEVA
  10.12.1 TEVA Company Details
  10.12.2 TEVA Business Overview and Its Total Revenue
  10.12.3 TEVA Osteoarthritis Therapeutics Introduction
  10.12.4 TEVA Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  10.12.5 TEVA Recent Development
13.13 Almatica Pharma
  10.13.1 Almatica Pharma Company Details
  10.13.2 Almatica Pharma Business Overview and Its Total Revenue
  10.13.3 Almatica Pharma Osteoarthritis Therapeutics Introduction
  10.13.4 Almatica Pharma Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  10.13.5 Almatica Pharma Recent Development
13.14 Astellas Pharma
  10.14.1 Astellas Pharma Company Details
  10.14.2 Astellas Pharma Business Overview and Its Total Revenue
  10.14.3 Astellas Pharma Osteoarthritis Therapeutics Introduction
  10.14.4 Astellas Pharma Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  10.14.5 Astellas Pharma Recent Development
13.15 Tide Pharmaceutical
  10.15.1 Tide Pharmaceutical Company Details
  10.15.2 Tide Pharmaceutical Business Overview and Its Total Revenue
  10.15.3 Tide Pharmaceutical Osteoarthritis Therapeutics Introduction
  10.15.4 Tide Pharmaceutical Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  10.15.5 Tide Pharmaceutical Recent Development
13.16 Iroko Pharmaceuticals
  10.16.1 Iroko Pharmaceuticals Company Details
  10.16.2 Iroko Pharmaceuticals Business Overview and Its Total Revenue
  10.16.3 Iroko Pharmaceuticals Osteoarthritis Therapeutics Introduction
  10.16.4 Iroko Pharmaceuticals Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  10.16.5 Iroko Pharmaceuticals Recent Development
13.17 Hengrui Pharmaceutical
  10.17.1 Hengrui Pharmaceutical Company Details
  10.17.2 Hengrui Pharmaceutical Business Overview and Its Total Revenue
  10.17.3 Hengrui Pharmaceutical Osteoarthritis Therapeutics Introduction
  10.17.4 Hengrui Pharmaceutical Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  10.17.5 Hengrui Pharmaceutical Recent Development
13.18 Abiogen Pharma
  10.18.1 Abiogen Pharma Company Details
  10.18.2 Abiogen Pharma Business Overview and Its Total Revenue
  10.18.3 Abiogen Pharma Osteoarthritis Therapeutics Introduction
  10.18.4 Abiogen Pharma Revenue in Osteoarthritis Therapeutics Business (2015-2020)
  10.18.5 Abiogen Pharma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Osteoarthritis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Osteoarthritis Therapeutics Revenue
Table 3. Ranking of Global Top Osteoarthritis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Osteoarthritis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Injection
Table 7. Key Players of External
Table 8. COVID-19 Impact Global Market: (Four Osteoarthritis Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Osteoarthritis Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Osteoarthritis Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Osteoarthritis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Osteoarthritis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Osteoarthritis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Osteoarthritis Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Osteoarthritis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Osteoarthritis Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Osteoarthritis Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Osteoarthritis Therapeutics Players
Table 24. Global Osteoarthritis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Osteoarthritis Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Osteoarthritis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoarthritis Therapeutics as of 2019)
Table 27. Global Osteoarthritis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Osteoarthritis Therapeutics Product Solution and Service
Table 30. Date of Enter into Osteoarthritis Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Osteoarthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Osteoarthritis Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Osteoarthritis Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Osteoarthritis Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Osteoarthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Osteoarthritis Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Osteoarthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Osteoarthritis Therapeutics Market Share (2019-2020)
Table 40. North America Osteoarthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Osteoarthritis Therapeutics Market Share by Type (2015-2020)
Table 42. North America Osteoarthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Osteoarthritis Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Osteoarthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Osteoarthritis Therapeutics Market Share (2019-2020)
Table 46. Europe Osteoarthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Osteoarthritis Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Osteoarthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Osteoarthritis Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Osteoarthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Osteoarthritis Therapeutics Market Share (2019-2020)
Table 52. China Osteoarthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Osteoarthritis Therapeutics Market Share by Type (2015-2020)
Table 54. China Osteoarthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Osteoarthritis Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Osteoarthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Osteoarthritis Therapeutics Market Share (2019-2020)
Table 58. Japan Osteoarthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Osteoarthritis Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Osteoarthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Osteoarthritis Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Osteoarthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Osteoarthritis Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Osteoarthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Osteoarthritis Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Osteoarthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Osteoarthritis Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Osteoarthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Osteoarthritis Therapeutics Market Share (2019-2020)
Table 70. India Osteoarthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Osteoarthritis Therapeutics Market Share by Type (2015-2020)
Table 72. India Osteoarthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Osteoarthritis Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Osteoarthritis Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Osteoarthritis Therapeutics Market Share (2019-2020)
Table 76. Central & South America Osteoarthritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Osteoarthritis Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Osteoarthritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Osteoarthritis Therapeutics Market Share by Application (2015-2020)
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Johnson & Johnson Company Details
Table 86. Johnson & Johnson Business Overview
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 89. Johnson & Johnson Recent Development
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Product
Table 93. GlaxoSmithKline Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline Recent Development
Table 95. Bayer Company Details
Table 96. Bayer Business Overview
Table 97. Bayer Product
Table 98. Bayer Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 99. Bayer Recent Development
Table 100. Eli Lilly Company Details
Table 101. Eli Lilly Business Overview
Table 102. Eli Lilly Product
Table 103. Eli Lilly Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 104. Eli Lilly Recent Development
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Product
Table 108. Novartis Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 109. Novartis Recent Development
Table 110. Sanofi Company Details
Table 111. Sanofi Business Overview
Table 112. Sanofi Product
Table 113. Sanofi Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 114. Sanofi Recent Development
Table 115. Horizon Pharma Business Overview
Table 116. Horizon Pharma Product
Table 117. Horizon Pharma Company Details
Table 118. Horizon Pharma Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 119. Horizon Pharma Recent Development
Table 120. Abbott Company Details
Table 121. Abbott Business Overview
Table 122. Abbott Product
Table 123. Abbott Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 124. Abbott Recent Development
Table 125. Mylan Company Details
Table 126. Mylan Business Overview
Table 127. Mylan Product
Table 128. Mylan Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 129. Mylan Recent Development
Table 130. Daiichi Sankyo Company Details
Table 131. Daiichi Sankyo Business Overview
Table 132. Daiichi Sankyo Product
Table 133. Daiichi Sankyo Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 134. Daiichi Sankyo Recent Development
Table 135. TEVA Company Details
Table 136. TEVA Business Overview
Table 137. TEVA Product
Table 138. TEVA Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 139. TEVA Recent Development
Table 140. Almatica Pharma Company Details
Table 141. Almatica Pharma Business Overview
Table 142. Almatica Pharma Product
Table 143. Almatica Pharma Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 144. Almatica Pharma Recent Development
Table 145. Astellas Pharma Company Details
Table 146. Astellas Pharma Business Overview
Table 147. Astellas Pharma Product
Table 148. Astellas Pharma Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 149. Astellas Pharma Recent Development
Table 150. Tide Pharmaceutical Company Details
Table 151. Tide Pharmaceutical Business Overview
Table 152. Tide Pharmaceutical Product
Table 153. Tide Pharmaceutical Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 154. Tide Pharmaceutical Recent Development
Table 155. Iroko Pharmaceuticals Company Details
Table 156. Iroko Pharmaceuticals Business Overview
Table 157. Iroko Pharmaceuticals Product
Table 158. Iroko Pharmaceuticals Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 159. Iroko Pharmaceuticals Recent Development
Table 160. Hengrui Pharmaceutical Company Details
Table 161. Hengrui Pharmaceutical Business Overview
Table 162. Hengrui Pharmaceutical Product
Table 163. Hengrui Pharmaceutical Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 164. Hengrui Pharmaceutical Recent Development
Table 165. Abiogen Pharma Company Details
Table 166. Abiogen Pharma Business Overview
Table 167. Abiogen Pharma Product
Table 168. Abiogen Pharma Revenue in Osteoarthritis Therapeutics Business (2015-2020) (Million US$)
Table 169. Abiogen Pharma Recent Development
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Osteoarthritis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. External Features
Figure 5. Global Osteoarthritis Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Medical Care Case Studies
Figure 7. Personal Care Case Studies
Figure 8. Osteoarthritis Therapeutics Report Years Considered
Figure 9. Global Osteoarthritis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Osteoarthritis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Osteoarthritis Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Osteoarthritis Therapeutics Market Share by Players in 2019
Figure 14. Global Top Osteoarthritis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoarthritis Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Osteoarthritis Therapeutics Revenue in 2019
Figure 16. North America Osteoarthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Osteoarthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Osteoarthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Osteoarthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Osteoarthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Osteoarthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Osteoarthritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Pfizer Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 25. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Johnson & Johnson Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 27. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GlaxoSmithKline Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 29. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bayer Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 31. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Eli Lilly Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 33. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 35. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sanofi Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 37. Horizon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Horizon Pharma Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 39. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Abbott Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 41. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Mylan Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 43. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Daiichi Sankyo Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 45. TEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. TEVA Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 47. Almatica Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Almatica Pharma Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 49. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Astellas Pharma Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 51. Tide Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Tide Pharmaceutical Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 53. Iroko Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Iroko Pharmaceuticals Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 55. Hengrui Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Hengrui Pharmaceutical Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 57. Abiogen Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Abiogen Pharma Revenue Growth Rate in Osteoarthritis Therapeutics Business (2015-2020)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed